Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes

被引:89
作者
Nguyen, May [1 ]
Eschenauer, Gregory A. [2 ]
Bryan, Monique [1 ]
O'Neil, Kelly [1 ]
Furuya, E. Yoko [3 ]
Della-Latta, Phyllis [4 ]
Kubin, Christine J. [1 ]
机构
[1] Columbia Univ, Med Ctr, NewYork Presbyterian Hosp, Dept Pharm, New York, NY 10032 USA
[2] Univ Pittsburgh, Med Ctr, Dept Pharm, Pittsburgh, PA 15213 USA
[3] Columbia Univ, Med Ctr, NewYork Presbyterian Hosp, Dept Med, New York, NY 10032 USA
[4] Columbia Univ, Med Ctr, NewYork Presbyterian Hosp, Dept Pathol, New York, NY 10032 USA
关键词
Polymyxin; Tigecycline; Carbapenem; Klebsiella; NEW-YORK-CITY; EPIDEMIOLOGY; INFECTION; EMERGENCE; SEVERITY; BROOKLYN; THREAT; IMPACT;
D O I
10.1016/j.diagmicrobio.2010.02.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We undertook a retrospective cohort study describing general outcomes and specific factors associated with positive outcomes in bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP). Forty-eight patients were included, of which 42% died at 30 days. Forty-two percent of patients were in septic shock at the time of the first positive blood culture, and 42% were recipients of solid organ transplants. Lack of microbiologic eradication at 7 days was independently associated with 30-day mortality. Adjunctive procedures performed for source control and microbiologic eradication at 7 days were associated with a favorable clinical response at 7 days. Time to initiation and receipt at any time of antimicrobials with in vitro activity against CRKP were not associated with improved survival. Breakthrough bacteremia occurred in 8 cases, all in patients receiving tigecycline. Our data suggest that severity of illness, rapid microbiologic eradication, and source control are crucial factors in the outcomes of patients with CRKP bacteremia. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 184
页数:5
相关论文
共 12 条
[1]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60
[2]   Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents [J].
Bratu, S ;
Tolaney, P ;
Karumudi, U ;
Quale, J ;
Mooty, M ;
Nichani, S ;
Landman, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :128-132
[3]   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[4]   Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection [J].
Bratu, S ;
Mooty, M ;
Nichani, S ;
Landman, D ;
Gullans, C ;
Pettinato, B ;
Karumudi, U ;
Tolaney, P ;
Quale, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :3018-3020
[5]   Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital [J].
Gootz, Thomas D. ;
Lescoe, Mary Kay ;
Dib-Hajj, Fadia ;
Dougherty, Brian A. ;
He, Wen ;
Della-Latta, Phyllis ;
Huard, Richard C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :1998-2004
[6]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829
[7]  
MUNOZPRICE LS, 2007, 45 INT C ANT AG CHEM
[8]   The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria [J].
Nordmann, Patrice ;
Cuzon, Gaelle ;
Naas, Thierry .
LANCET INFECTIOUS DISEASES, 2009, 9 (04) :228-236
[9]   Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies [J].
Patel, Gopi ;
Huprikar, Shirish ;
Factor, Stephanie H. ;
Jenkins, Stephen G. ;
Calfee, David P. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (12) :1099-1106
[10]   Acinetobacter baumannii bloodstream infection while receiving tigecycline:: a cautionary report [J].
Peleg, Anton Y. ;
Potoski, Brian A. ;
Rea, Rhonda ;
Adams, Jennifer ;
Sethi, Jigme ;
Capitano, Blair ;
Husain, Shahid ;
Kwak, Eun J. ;
Bhat, Sunil V. ;
Paterson, David L. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) :128-131